FindTrial
Sign In

Cross sectional area and wall thickness of gastric antrum during the induction sequence with 2mg /kg propofol, 0.6 mg/kg rocuronium and 0.05ug/kg sufentanil and the prediction of postoperative nausea and vomiting

Cross sectional area and wall thickness of gastric antrum during the induction sequence with 2mg /kg propofol, 0.6 mg/kg rocuronium and 0.05ug/kg sufentanil and the prediction of postoperative nausea and vomiting

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057976
Enrollment
Unknown
Registered
2022-03-24
Start date
2022-03-24
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative nausea and vomiting

Interventions

None listed

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with an American Society of Anesthesiologists score of I or II; 2. Patients undergoing elective endotracheal intubation and general anesthesia.

Exclusion criteria

Exclusion criteria: 1. The patient refused; 2. Pregnant women; 3. Patients with a history of gastroesophageal surgery, diabetic gastroparesis, advanced liver or renal insufficiency, serious heart and lung diseases, or critical illness; 4. Emergency surgery; 5. A long history of taking analgesic drugs; 6. Unable to cooperate with language communication disorder, mental illness, etc.

Design outcomes

Primary

MeasureTime frame
Cross sectional area of gastric antrum;Antral wall thickness;Postoperative nausea and vomiting;—

Countries

China

Contacts

Public ContactYaping Lu

The First Hospital of Jiaxing

18967307976@189.cn+86 18967307976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026